Spnib 50 mg Tablet
  1. Home
  2. Pharma Products
  3. Cadila Healthcare Ltd
  4. Spnib 50 mg Tablet

Spnib 50 mg Tablet

Spnib 50 mg Tablet contains dasatinib, a tyrosine kinase inhibitor used to treat certain blood cancers. It is an oral medicine mainly used for chronic myeloid leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL). Dasatinib blocks abnormal proteins that promote the growth of cancer cells.

BUY NOW

Category

Spnib 50 mg Tablet works by inhibiting BCR-ABL and other tyrosine kinases involved in abnormal blood-cell growth. This targeted action helps slow or stop the multiplication of leukemia cells and supports disease control. The medicine can be taken with or without food according to the prescribed treatment plan. Regular medical monitoring is recommended during therapy to assess blood counts and treatment response.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 50 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 60 Tablets
Manufacturer/Marketer Zydus Healthcare Ltd

Product Also Known As

Spnib 50 mg Tablet, Spnib 50 Tablet, Spnib 50, Dasatinib 50 mg Tablet, Dasatinib Cancer Tablet, Dasatinib Leukemia Tablet